MYC and hepatocellular carcinoma: Additionally, various molecular mechanisms underpinning MYC deregulation in HCC have been reported, including MYC amplification, point mutations promoting MYC stability, and β‐catenin pathway activation.67, 68, 69, 70, 71, 72